OM:GENOLife Sciences
Genovis (OM:GENO) Stock Faces Margin Compression As Net Profitability Undercuts Bullish Growth Narratives
Genovis AB (publ.) (OM:GENO) has posted its Q2 2026 numbers with revenue of SEK38.0 million and basic EPS of SEK0.02, alongside trailing 12 month totals of SEK142.1 million in revenue and SEK0.31 in EPS that frame the latest quarter within a broader earnings profile. Over recent periods the company has seen revenue range from SEK27.7 million to SEK40.5 million per quarter while basic EPS has moved between SEK0.02 and SEK0.12, giving investors a clear view of how the latest print fits into the...